Union City, CA, United States of America

Qiang Wang

USPTO Granted Patents = 41 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 4)

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 293(Granted Patents)

Location History:

Baltimore, MD (US) (2000)
Newark, CA (US) (2002 - 2012)
Union City, CA (US) (2011 - 2021)
Sunnyvale, CA (US) (2019 - 2024)
San Carlos, CA (US) (2019 - 2024)

Company Filing History:

23 out of 4,731

Juniper Networks, Inc.

The Johns Hopkins University

patents

5. 2 out of 15

Apollo Autonomous Driving USA LLC

Apollo Intelligent Driving Technology (beijing) Co., Ltd.

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

41 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12353868 - Firmware over-the-air (FOTA) failure reduction for autonomous driving vehicle (2025-07-08),

2. 12323645 - Scalable video compression accelerator for autonomous driving (2025-06-03),

3. 12107680 - Monitoring burst errors in forward error correction frames (2024-10-01),

4. 12086090 - Uniform virtual bus for system-to-system connectivity in an autonomous driving vehicle (2024-09-10),

5. 12028660 - Cascaded optical switch (2024-07-02),

6. 11637637 - Hybrid compensation of chromatic dispersion in optical networks (2023-04-25),

7. 11522616 - Methods and apparatus for optical communications via pulse amplitude modulation (PAM) in dense wavelength-division multiplexing (DWDM) systems (2022-12-06),

8. 11433061 - Heteroaryl sulfonamides and CCR2/CCR9 (2022-09-06),

9. 11177888 - Methods and apparatus for optical communications via pulse amplitude modulation (PAM) in dense wavelength-division multiplexing (DWDM) systems (2021-11-16),

10. 11088765 - Methods and apparatus for detecting and compensating bandwidth limitation and modulation nonlinearity of a coherent optical transponder (2021-08-10),

11. 10917191 - Methods and apparatus for improving the skew tolerance of a coherent optical transponder in an optical communication system (2021-02-09),

12. 10903910 - Methods and apparatus for optical communications via pulse amplitude modulation (PAM) in dense wavelength-division multiplexing (DWDM) systems (2021-01-26),

13. 10899765 - Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation (2021-01-26),

14. 10644821 - Methods and apparatus for adaptive compensation of signal bandwidth narrowing through finite impulse response filters (2020-05-05),

15. 10623094 - Methods and apparatus for predicting and monitoring performance of a coherent optical transceiver (2020-04-14),

Title: Innovations and Contributions of Qiang Wang in Optical Communications and Pharmaceutical Research

Introduction: Qiang Wang, a prolific inventor hailing from Union City, California, has made significant strides in the realm of technology and pharmaceuticals. With an impressive portfolio of 32 patents, his innovative approaches have revolutionized how optical communications are conducted and provided new avenues for treating CCR2-mediated diseases.

Latest Patents: Among his latest patents are groundbreaking methods and apparatus for optical communications utilizing pulse amplitude modulation (PAM) in dense wavelength-division multiplexing (DWDM) systems. This innovative method encompasses the application of forward error correction (FEC) using low-density parity-check (LDPC) algorithms to enhance digital signal transmission. Additionally, Qiang Wang has developed heteroaryl sulfonamides that serve as potent antagonists of the CCR2 receptor, demonstrating potential in treating inflammation. These compounds, generally aryl sulfonamide derivatives, not only benefit pharmaceutical compositions but also assist in the identification of CCR2 antagonists through testing.

Career Highlights: Qiang Wang has further expanded his expertise through his work at notable companies such as Juniper Networks, Inc. and Chemocentryx, Inc. His time in these organizations has allowed him to grow as an inventor while contributing to various technological and medicinal advancements.

Collaborations: Throughout his career, Qiang Wang has collaborated with esteemed colleagues including Yang Yue and Antoni Krasinski. These partnerships have fostered a rich exchange of ideas and innovation, facilitating the development of cutting-edge solutions in both optical communications and pharmaceutical research.

Conclusion: Qiang Wang's contributions to the fields of optical communications and medicine underscore his role as a leading inventor. With his extensive patent portfolio and impactful collaborations, he continues to inspire advancements that address contemporary challenges in technology and health.

This text is generated by artificial intelligence and may not be accurate.